Elevating real-world data (RWD) to the status of regulatory-grade evidence will bring both opportunity and challenges to the industry.
Fabio Lievano, MD, PhD
Advertisement
Fabio Lievano, MD, PhD, is a distinguished physician and epidemiologist with extensive experience in the pharmaceutical industry, global public health, digital health innovation, and academic leadership. Dr. Lievano holds appointments as Associate Professor of Pharmacology and Neuroscience at Northwestern University and Loyola University Chicago.
Articles by Fabio Lievano, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Are Regulatory Factors Impacting Biosimilars
2
Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement
3
Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology
4
A New Standard for Copay Excellence: Q&A with Brian Laird
5